Business Context and Reporting Period
Bleichroeder Acquisition Corp. II, a Cayman Islands-based emerging growth company, filed this Form 8-K on January 9, 2026, to report the consummation of its initial public offering (IPO). The company is incorporated in the Cayman Islands with principal executive offices in New York, NY.
Key Financial Metrics
- Gross Proceeds from IPO: $287,500,000 from the sale of 28,750,000 Units at $10.00 per Unit.
- Private Placement Proceeds: $7,750,000 from the sale of 7,750,000 Private Placement Warrants at $1.00 per warrant.
- Total Funds in Trust: $287,500,000 ($10.00 per Unit) placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company.
- Deferred Underwriting Discount: Up to $12,250,000 included in the trust proceeds.
- Warrant Exercise Price: $11.50 per share for public warrants.
Material Changes
This filing represents the company's initial public offering. There is no prior comparable period for revenue or operating metrics as the company was previously a private entity. The primary material change is the transition to a public company with significant cash liquidity held in trust for potential future business combinations.
Outlook, Risks, and Management Commentary
The company has completed its IPO and private placement, securing the necessary capital to pursue a business combination. The filing includes an audited balance sheet as of January 9, 2026, reflecting these proceeds. As an emerging growth company, the registrant has elected to use the extended transition period for complying with new or revised financial accounting standards. No specific risks or contingencies beyond standard SPAC structures are detailed in this specific text excerpt.
Investor Verification Checklist
- Verify the full exercise of the 3,750,000 Unit over-allotment option by underwriters.
- Confirm the terms of the deferred underwriting discount of up to $12,250,000.
- Review the audited balance sheet (Exhibit 99.1) for the exact cash position and liabilities as of January 9, 2026.
- Check the specific redemption rights and warrant exercise conditions detailed in the full prospectus.